Rheumnow Podcast

Bimekizumab in Active AS_ 5 Year Study Deep Neural Networks and Radiographic Progression in AxSpA Difficult to Treat axSpA From AS Patient to Rheumatologist Imaging Updates in SpA INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Monitoring the Effect of Therapy with a...Smart Watch_ Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA SpA Insights_ New Therapies Teledidactic vs On Campus Training in Musculoskeletal Ultrasound Treatments in SpA Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA

Another TYK2 Ticks the Boxes Correlation Between Patient and Physicians Assessments in PsA Difficult to Treat axSpA Effects of Apremilast on Cardiometabolic Effects in PsA EHR Algorithms Identify PsA Patients Is MSOT the New Ultrasound_ Is Point of Care Ultrasound Hocus Pocus_ SpA Insights_ New Therapies Teledidactic vs On Campus Training in Musculoskeletal Ultrasound The FOREMOST Study_ Apremilast in PsA Ultrasound for PsA Stratification_ Are We There Yet_ Window of Opportunity in PsA

Join Drs. Jack Cush and Arthur Kavanaugh as they discuss highlights and key takeaways from ACR 23.

Join our live topic panel discussion!

Join our live topic panel discussion!

Join our topic panel as we discuss Rheumatoid Arthritis.

Join our topic panel discussion on Psoriatic Arthritis!

Join us live for our daily recap of ACR2023!

Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at the 2023 ACR Convergence meeting in San Diego, CA.

Bimekizumab in Active AS_ 5 Year Study INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep